Keywords
Early Diagnosis
Primary Health Care
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To extract information about the early diagnosis of leprosy in Primary Health Care. Methods: This is an integrative review of scientific studies selected from the PubMed platforms and the Regional Portal of the Virtual Health Library (VHL), using the terms Leprosy, early diagnosis, and Primary Health Care as search descriptors. Full articles from June 2014 and June 2024, in Portuguese and English, were included. Systematic reviews, case studies, case reports, editorials, and dissertation and thesis studies were excluded. Results: A total of 12 articles were selected, and their contents were directly related to the theme of early diagnosis in leprosy. Conclusion: Early diagnosis is extremely relevant in the fight against and control of leprosy in Primary Health Care, especially in reducing cases of physical disability and damage to the quality of life of patients.
References
ARAÚJO MG. Hanseníase no Brasil. Revista da Sociedade Brasileira de Medicina Tropical, 2003; 36:373-382.
BETRU KT, MAKUA T. Challenges Experienced and Observed during the Implementation of Leprosy Strategies, Sidama Region, Southern Ethiopia: An inductive thematic analysis of qualitative study among health professionals who working with leprosy programs. PLOS Neglected Tropical Diseases, 2023; 17(11): e0011794.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Boletim Epidemiológico Hanseníase. Número Especial. 2024. 20 p. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemioloEtapasgicos/especiais/2024/be_hansen-2024_19jan_final.pdf. Acessado em: 25 de junho de 2024.
CAVALCANTE MDMA, et al. Múltiplas dimensões da gestão do cuidado à hanseníase e os desafios para a eliminação. Revista da Escola de Enfermagem da USP, 2020; 54:e03649.
COSTA MR, et al. A cost-effectiveness analysis of a novel algorithm to sequentially diagnose leprosy based on manufactured tests under the SUS perspective. Cadernos de Saúde Pública, 2024; 40: e00038723.
DE OLIVEIRA SERRA MAA, et al. Individual, socioeconomic and healthcare access factors influencing the delays in leprosy presentation, diagnosis and treatment: a qualitative study. Transactions of The Royal Society of Tropical Medicine and Hygiene, 2023; 117(12): 852-858.
FROES LAR, et al. Leprosy: clinical and immunopathological characteristics. Anais Brasileiros de Dermatologia, 2022; 97(3): 338-347.
GOVINDASAMY K, et al. A comparison of three types of targeted, community-based methods aimed at promoting early detection of new leprosy cases in rural parts of three endemic states in India. Plos one, 2021; 16(12):e0261219.
GUERRERO M, et al. Retraso en el diagnóstico de lepra como factor pronóstico de discapacidad en una cohorte de pacientes en Colombia, 2000-2010. Revista Panamericana de Salud Pública, 2013; 33: 137-143.
JESUS ILR, et al. Hanseníase e vulnerabilidade: uma revisão de escopo. Ciência & Saúde Coletiva, 2023; 28:143-154.
KUKKARO P, et al. Target product profiles: leprosy diagnostics. Bulletin of the World Health Organization, 2024; 102(4): 288.
LEMA T, et al. Reaching those at risk: Active case detection of leprosy and contact tracing at Kokosa, a hot spot district in Ethiopia. Plos one, 2023; 18(6):e0264100.
MAMO E, et al. Training and active case detection to prevent Leprosy: Effect on knowledge, attitude and skills of health workers on early diagnosis of leprosy in a leprosy hotspot district in Ethiopia. Tropical Medicine and Infectious Disease, 2024; 9(3):51.
MARCIANO AFN, et al. Tempo para o diagnóstico da hanseníase e sua relação com fatores sociodemográficos e clínicos. Ciencia, Cuidado e Saude,2020; 19: e53976.
MORAES PC, et al. Epidemiological characteristics of leprosy from 2000 to 2019 in a state with low endemicity in southern Brazil. Anais Brasileiros de Dermatologia, 2023; 98: 602-610.
ORGANIZAÇÃO MUNDIAL DA SAÚDE (OMS). Estratégia Global de Hanseníase 2021–2030 – “Rumo à zero hanseníase”. 2021. 30 p. Disponível em: https://www.who.int/pt/publications/i/9789290228509. Acessado em: 25 junho de 2024.
SHEN YL, et al. Suspicious symptom monitoring for leprosy: an optimal practice for early detection under a low endemic situation in Zhejiang Province, China. International Journal of Dermatology, 2022; 61(12): 1532-1539.
SHUMET T, et al. Prevalence of disability and associated factors among registered leprosy patients in all Africa tb and leprosy rehabilitation and training centre (ALERT), Addis Ababa, Ethiopia. Ethiopian journal of health sciences, 2015; 25(4): 313-320.
SILVA JSR, et al. Variáveis clínicas associadas ao grau de incapacidade física na hanseníase. Revista Cuidarte, 2019; 10(1): e618.
SOUZA MT, et al. Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 2010; 8: 102106.
VAN BRAKEL W, et al. Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination. Global health action, 2012; 5(1): 18394.
VIEIRA NF, et al. Primary care quality and its effects on leprosy monitoring indicators. Revista Brasileira de Enfermagem, 2020; 73(4): e20190038.